Abrams, H.L.: Angiography, p. 3. Vol. 1. Little, Brown & Co., 1961.
2.
Albert, A.: Selective Toxicity, p. 3. John Wiley & Sons, Inc.New York, 1965.
3.
Hoppe, J.O., Larsen, A.A., and Coulston, F.: Observations on the toxicity of a new urographic contrast medium, sodium 3,5-diacetamido-2,4,6-triiodobenzoate (Hypaque Sodium) and related compounds. J. Pharmacol. and Exper. Therap., 116: 394, 1956.
von Lichtenberg : Principles and new advances in excretion urography. Brit. J. Urol., 3: 119, 1931.
6.
Swick, M.: Excretion urography, with particular reference to a newly developed compound: sodium ortho-iodohippurate. J.A.M.A., 101: 1853, 1933 .
7.
Wallingford, V.H., Decker, H.G. and Kruty, M.: X-Ray contrast media. I. Iodinated acylaminobenzoic acids. J. Am. Chem. Soc., 74: 4365, 1952.
8.
Moore, C., Cloke, B., Hoppe, J.O., and Larsen, A.A.: Iodinated 3,5-diaminobenzoic acid derivatives. Abstr. 125th MeetingAm. Chem. Soc., New York, N Y. Sept. 12-17, 1954, p. 11 N.
Langecker, H., Harwart, A., and Junkmann, K.: 3,5-Diacetylamino-2,4,6-triijodbenzoesäure als Röntgen kontrastmittel. Arch. exper. Path. u. Pharmakol. , 222: 584, 1954.
11.
Hoey, G.B.: Procédé de preparation de nouveaux dérivés d'acide isophthalique. Belgian Patent, 607, 551, Feb. 26, 1962.
12.
Kodama, J.K., Butler, W.M., Tusing, T.W. and Hallett, F.P.: Iothalamate: A new intravascular radiopaque medium with unusual pharmacotoxic inertness. Exper. and Molecular Pathol., (Suppl.) 2: 65, 1963.
13.
Holtermann, H. : Symposium on metrizoate sodium (Isopaque), a new contrast medium for angiography and urography. Farmakoterapi , 18: 1, 1962.
14.
Holtermann, H., Willie, K., and Haugen, L.G.: Agent de contraste pour rayons X dérivé de l'acide 3,5-diamino-2,4,6-triiodobenzoique . Belgian Patent, No. 597, 848, June 16, 1961.
15.
Felder, E., Pitre, D., and Fumagaui, L.: Röntgenkontrastmittel. 6. Mitterlung. Jodierte derivative der 3-aminoethylbenzoesäure . Helv. Chim. Acta, 48: 259, 1965.
16.
Fischer, H.W. : Viscosity, solubility and toxicity in the choice of an angiographic contrast medium. Angiology, 16: 759, 1965.
17.
Brodie, B.B. , and Hogben, A.C.M.: Some physico-chemical factors in drug action. J. Pharm. Pharmacol., 9: 345, 1957.
18.
McChesney, E.W., and Hoppe, J.O.: Studies of the tissue distribution and excretion of sodium diatrizoate in laboratory animals. Am. J. Roentgenol. Rad. Therap. Nuc. Med., 78: 137, 1957.
19.
Tauxe, U.N. , Burbank, M.K., Maher, F.T., and Hunt, J.C.: Renal clearances of radioactive ortho-iodohippurate and diatrizoate. Mayo Clinic Proc., 39: 761, 1964.
20.
Hoppe, J.O. : Some pharmacological aspects of radiopaque compounds. Ann. N. Y. Acad. Sci., 78: 727, 1959.
21.
Hoppe, J.O. , and Archer, S.: X-ray contrast media for cardiovascular angiography . Angiology. 11. pt. 2. 244, 1960.
22.
Fischer, H.W. , and Eckstein, J.W.: Comparison of cerebral angiographic contrast media by their circulatory effects. An experimental study. Am. J. Roentgenol. Rad. Therap. Nuc. Med., 86: 166, 1961.
23.
Fischer, H.W. , and Cornell, S.H.: The toxicity of the sodium and methylglucamine salts of diatrizoate, iothalamate and metrizoate. Radiology , 85: 1013, 1965.
24.
Hilal, S.K. : Hemodynamic changes associated with the intra-arterial injection of contrast media. Radiology, 86: 615, 1966.
25.
Gensini, G.G. , and DiGiorgi, S.: Myocardial toxicity of contrast agents used in angiography. Radiology, 82: 24, 1964.
26.
Fujii, K., Grayson, T., Margulis, A.R., and Saltzstein, S.L. : The effects of intra-arterial injection of contrast media on canine intestine. Am. J. Roentgenol. Rad. Therap. Nuc. Med., 89: 730, 1963.
27.
Hoppe, J.O. , and Brousseau, A.: A study of the local tissue toxicity effects of sodium diatrizoate on the cerebral vasculature. J. Pharmacol. and Exper. Therap., 122: 32A, 1958.
28.
Broman, T., and Olsson, O.: The tolerance of cerebral blood vessels to a contrast medium of the diodrast group. Acta. radiol., 30: 326, 1948.
29.
Sollmann, T.: A Manual of Pharmacology. 7th ed. P. 730, W. B. Saunders Co., Philadelphia, 1948.
30.
Bird, J.G.: Aqueous radiopaque solutions containing sodium and calcium ions. United States Patent No. 3,175,952, March 30, 1965.
31.
Busfield, D. , Child, K.J., and Tomich, E.G.: Pharmacological and toxicological studies on Triosil, an intravenous contrast agent. Brit. J. Radiol. , 35: 815, 1962.
32.
Arnesen, K. : III. Pathological-anatomical investigations . Farmakoterapi, 18: 9, 1962.
33.
Aakhus, T., and Semb, G.: Coronary angiography during acetylcholine-induced cardiac arrest in the dog . Acta Radiologica, 3: 9, 1965.
34.
Amundsen, P. : II. Metrizoate sodium (Isopaque), a new contrast medium for angiography and urography. Evaluation, initial clinical testing and clinical experience. Farmakoterapi, 18: 3, 1962.
35.
Amundsen, P. : Double-blind test in a comparison of angiographic contrast media for intravascular use. Acta Radiologica, 3: 335, 1965.
36.
Lyngsted Jepsen, O., and Fog, J.: IV. Isopaque—A clinical evaluation . Farmakoterapi, 18: 13, 1962.
37.
Stevenson, J.J.: V. Experience with Isopaque in intravenous pyelography. Farmakoterapi,18: 18, 1962.
38.
Bull, J.W.D. , and Murray-Leslie , R.M.: VII. Experience with metrizoate sodium (Isopaque) in cerebral angiography. A report on 33 cases . Farmakoterapi, 18: 24, 1962.
39.
Pattinson, J.N.: Sodium metrizoate. Clinical experience with a new contrast medium in angiocardiography. Brit. J. Radiol., 35: 824, 1962.
40.
Pattinson, J.N.: VI. Experience with sodium metrizoate (cardiography) . Farmakoterapi, 18: 20, 1962.
41.
Salvesen, S., Nilsen, P.L., and Holtermann, H.: Ameliorating effect of calcium and magnesium ions on the toxicity of Isopaque sodium. I. Acute toxicities and toxicities in the brain. Acta Radiol. In press.
42.
Salvesen, S., Nilsen, P.L., and Holtermann, H.: Ameliorating effect of calcium and magnesium ions on the toxicity of Isopaque. II. Perfusion studies in the isolated rabbit heart. Acta. radiol. In press.
43.
Brown, T.G., Jr., Hoppe, J.O., and Borisenok, W.A.: Cardiovascular studies of Isopaque B and other radiopaque media. Acta Radiologica. In press.
